Table 3: Surface marker expression of PBMCs and LCLs derived from participated subjects.

Sample type and annotationSurface marker expression (%) standard deviation
CD3+CD19+CD19+CD23+CD19+CD27+CD19+CD23+CD27+

1BPBMC-1B66.585.623.920.360.01
LCL-1B0.0281.19 0.7749.26 1.2617.75 1.516.63 0.93
2CPBMC-2C78.726.075.571.560.41
LCL-2C0.06 0.0386.61 0.3839.57 0.2553.66 0.5620.59 0.31
5BPBMC-5B44.1014.027.973.730.25
LCL-5B0.09 0.0579.47 0.3138.52 0.1651.5 1.0319.09 0.68
6A#PBMC-6A-19.419.53.71.0
LCL-6A#-77.427.439.711.06
7BPBMC-7B72.2710.958.701.490.22
LCL-7B0.01 0.0280.58 1.2848.06 1.2923.34 5.768.79 3.13
8APBMC-8A66.616.217.92.341.24
LCL-8A0.14 0.2186.0 0.8358.9 2.5834.4 4.9017.6 1.37
9DPBMC-9D49.572.562.060.180.03
LCL-9D0.02 0.0171.32 0.8743.17 0.7015.74 0.285.72 0.22
10EPBMC-10E34.1523.5822.573.890.64
LCL-10E076.59 0.5144.72 0.2443.94 0.0319.54 0.18
11APBMC-11A59.4513.028.753.740.57
LCL-11A0.05 0.0168.59 0.7316.94 0.3748.83 1.108.89 0.30
12APBMC-12A48.279.107.585.420.53
LCL-12A0.05 0.0172.70 1.2018.29 0.4051.64 1.119.73 0.21
13BPBMC-13B29.7845.9513.611.650.10
LCL-13B0.01 + 0.0174.95 + 1.4252.87 + 1.5420.18 + 1.5112.74 + 1.2
15APBMC-15A10.462.351.931.120.11
LCL-15A088.84 + 1.7219.47 + 0.4680.89 + 0.8217.78 + 0.49
16APBMC-16A81.89.669.742.660.82
LCL-16A0.27 0.4172.8 0.6443.7 1.8150.6 8.6326.0 3.05
17APBMC-17A69.2811.6410.663.390.61
LCL-17A089.35 + 1.0341.15 + 2.0780.06 + 1.5941.53 + 0.65
CPBMC-C75.516.315.41.850.59
LCL-C0.10 0.1470.6 1.7344.1 4.0437.9 0.2417.6 1.80

LCL: lymphoblastoid cell line; PBMC: peripheral blood mononuclear cell.
#Flow cytometric analysis for all surface markers was only performed once and CD3 levels were not determined due to the limitation of cell number.